Psoriasis and steatotic liver disease: Are PNPLA3 and TM6SF2 polymorphisms suitable for the hepato-dermal axis hypothesis? Luciana Agoglia; Ana Carolina Cardoso; Lívia Barbosa; Cecília Schubert Xavier Lagalhard Victer; Sueli Carneiro; Paulo Henrique Condeixa de França; Maria Chiara Chindamo; Cristiane Alves Villela-Nogueira;

Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents Andrea del Carmen Maldonado-Rojas; Julia María Zuarth-Vázquez; Misael Uribe; Varenka J Barbero-Becerra;

A data-driven approach to decode metabolic dysfunction-associated steatotic liver disease Maria Jimenez Ramos; Timothy J. Kendall; Ignat Drozdov; Jonathan A. Fallowfield;